Animal experiments show that LC16 can significantly increase rat bone density, promote calcium absorption, and rat osteoblast proliferation, inhibit osteoclasts, regulate bone metabolism, reduce the risk of osteoporosis, and improve bone health. At the same time, LC16 can produce short-chain fatty acids, lower the local pH value of the intestine, reduce the formation of complexes between intestinal calcium ions and phosphorus, and promote calcium absorption.

Animal experiments show that LC86 can synergize with LC16 to promote bone health and reduce the risk of osteoporosis.

Used in combination with LC16 and LC86, it can significantly stimulate the proliferation, differentiation and maturation of osteoblasts, produce short-chain fatty acids that have a direct effect on osteoblasts, directly act on osteoblasts and osteoclasts, and regulate the interaction between them. balance, thereby improving bone quality.

It has strong antibacterial ability and intestinal epithelial cell adhesion ability, and can also regulate the body's immunity by affecting the levels of cytokines.

It can enhance immune function by inhibiting weight loss, alleviating spleen enlargement and thymus atrophy, regulating related cytokines and immunoglobulins, etc. It can also repair intestinal damage and intestinal flora disorders caused by immune disorders, and help facilitate the function of other probiotics in the gut microbiota.